Literature DB >> 19566500

The histopathology of grey matter demyelination in multiple sclerosis.

L Bø1.   

Abstract

Multiple sclerosis (MS) is characterized by focal demyelinating lesions in white matter (WM) and grey matter (GM) of the central nervous system. Results of studies using quantitative magnetic resonance imaging techniques indicate that GM MS pathology has a significant impact on clinical symptoms and disability in MS, and may occur partly independently of WM pathology. Subpial cerebral and cerebellar cortexes are predilection sites for demyelination in MS. Significant neuronal and axonal pathology has been detected in GM MS lesions. The pathology of MS lesions is location-dependent; there is less pronounced inflammation in GM lesion areas than in WM lesions. The presence and extent of GM lesions has recently been correlated to meningeal inflammation, and cells infected with the Epstein-Barr virus have been detected in meningeal infiltrates, suggesting a role of meningeal inflammation in cortical lesion pathogenesis.

Entities:  

Mesh:

Year:  2009        PMID: 19566500     DOI: 10.1111/j.1600-0404.2009.01216.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  16 in total

1.  Neuronopathy in the motor neocortex in a chronic model of multiple sclerosis.

Authors:  Travis Burns; Laird Miers; Jie Xu; Alan Man; Monica Moreno; David Pleasure; Peter Bannerman
Journal:  J Neuropathol Exp Neurol       Date:  2014-04       Impact factor: 3.685

Review 2.  The immunopathophysiology of multiple sclerosis.

Authors:  Gregory F Wu; Enrique Alvarez
Journal:  Neurol Clin       Date:  2011-05       Impact factor: 3.806

3.  An animal model of cortical and callosal pathology in multiple sclerosis.

Authors:  Mario Mangiardi; Daniel K Crawford; Xiaoyu Xia; Sienmi Du; Rebecca Simon-Freeman; Rhonda R Voskuhl; Seema K Tiwari-Woodruff
Journal:  Brain Pathol       Date:  2010-11-10       Impact factor: 6.508

Review 4.  Initial immunopathogenesis of multiple sclerosis: innate immune response.

Authors:  Norma Y Hernández-Pedro; Guillermo Espinosa-Ramirez; Verónica Pérez de la Cruz; Benjamín Pineda; Julio Sotelo
Journal:  Clin Dev Immunol       Date:  2013-09-24

5.  Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis.

Authors:  Marloes Prins; Charlotta Eriksson; Anne Wierinckx; John G J M Bol; Rob Binnekade; Fred J H Tilders; Anne-Marie Van Dam
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

6.  Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

Authors:  Florian Kurth; Eileen Luders; Nancy L Sicotte; Christian Gaser; Barbara S Giesser; Ronald S Swerdloff; Michael J Montag; Rhonda R Voskuhl; Allan Mackenzie-Graham
Journal:  Neuroimage Clin       Date:  2014-03-06       Impact factor: 4.881

7.  Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.

Authors:  Nathaly Espitia Pinzon; Esther Stroo; Bert A 't Hart; John G J M Bol; Benjamin Drukarch; Jan Bauer; Anne-Marie van Dam
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

8.  Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology.

Authors:  Christine L Tardif; Barry J Bedell; Simon F Eskildsen; D Louis Collins; G Bruce Pike
Journal:  Mult Scler Int       Date:  2012-11-18

9.  Cognitive and clinical dysfunction, altered MEG resting-state networks and thalamic atrophy in multiple sclerosis.

Authors:  Prejaas Tewarie; Menno M Schoonheim; Cornelis J Stam; Marieke L van der Meer; Bob W van Dijk; Frederik Barkhof; Chris H Polman; Arjan Hillebrand
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

Review 10.  The Role of Astrocytes in Multiple Sclerosis Progression.

Authors:  Jorge Correale; Mauricio F Farez
Journal:  Front Neurol       Date:  2015-08-18       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.